TGFB1 and renal carcinoma: Contradictory results were presented by Zheng et al., who demonstrated downregulation of TGF-β1 expression in metastatic renal cancer tissue compared to primary tumor samples, suggesting DNA hypermethylation as a possible cause of decreased expression.